Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

ONTOLOGY REPORT - ANNOTATIONS


Term:(-)-duryne F
go back to main search page
Accession:CHEBI:67759 term browser browse the term
Definition:An enyne that is (4E,15Z,29Z)-dotriaconta-4,15,29-triene-1,31-diyne substituted by hydroxy groups at positions 3 and 28 (the 3R,28S-stereoisomer). It has been isolated from the marine sponge Petrosia.
Synonyms:exact_synonym: (3R,4E,15Z,28S,29Z)-dotriaconta-4,15,29-triene-1,31-diyne-3,28-diol
 related_synonym: Formula=C32H52O2;   InChI=1S/C32H52O2/c1-3-5-28-32(34)30-27-25-23-21-19-17-15-13-11-9-7-6-8-10-12-14-16-18-20-22-24-26-29-31(33)4-2/h1-2,5-7,26,28-29,31-34H,8-25,27,30H2/b7-6-,28-5-,29-26+/t31-,32+/m0/s1;   InChIKey=VIAGOLXCGUWNRZ-INHMWYDMSA-N;   SMILES=O[C@@H](CCCCCCCCCCC\\C=C/CCCCCCCCC\\C=C\\[C@@H](O)C#C)\\C=C/C#C
 xref: PMID:21534590 "Europe PMC";   Reaxys:21556539 "Reaxys"


show annotations for term's descendants       view all columns           Sort by:
 

Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 19596
    role 19539
      application 19135
        pharmaceutical 19038
          drug 19038
            antineoplastic agent 16533
              (-)-duryne F 0
Path 2
Term Annotations click to browse term
  CHEBI ontology 19596
    subatomic particle 19592
      composite particle 19592
        hadron 19592
          baryon 19592
            nucleon 19592
              atomic nucleus 19592
                atom 19592
                  main group element atom 19471
                    p-block element atom 19471
                      chalcogen 19183
                        oxygen atom 19138
                          oxygen molecular entity 19138
                            hydroxides 18924
                              organic hydroxy compound 18442
                                polyol 7555
                                  diol 2680
                                    (-)-duryne F 0
paths to the root

NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.